Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Horizon Therapeutics Public Limited Company (HZNP)

25.83   -1.13 (-4.19%) 05-17 16:00
Open: 26.8 Pre. Close: 26.96
High: 26.875 Low: 25.71
Volume: 1,290,861 Market Cap: 4776M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 26.943 - 27.075 27.075 - 27.183
Low: 25.35 - 25.527 25.527 - 25.671
Close: 25.584 - 25.85 25.85 - 26.066

Technical analysis

as of: 2019-05-17 4:29:14 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 31.89     One year: 34.19
Support: Support1: 24.12    Support2: 20.07
Resistance: Resistance1: 27.30    Resistance2: 29.27
Pivot: 26.83
Moving Average: MA(5): 26.63     MA(20): 26.42
MA(100): 24.40     MA(250): 21.05
MACD: MACD(12,26): 0.20     Signal(9): 0.27
Stochastic oscillator: %K(14,3): 34.10     %D(3): 41.71
RSI: RSI(14): 44.72
52-week: High: 29.44  Low: 14.89  Change(%): 70.9
Average Vol(K): 3-Month: 202258  10-Days: 170714

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
HZNP has closed above bottom band by 21.9%. Bollinger Bands are 14.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 09 May 2019 23:56:33 Z
Horizon Therapeutics' (HZNP) Q1 Earnings Beat Estimates

Wed, 08 May 2019 21:00:11 Z
Here's How Horizon Therapeutics Blew Past Wall Street Estimates in Q1

Wed, 08 May 2019 19:28:14 Z
Horizon Pharma PLC (HZNP) Q1 2019 Earnings Call Transcript

Wed, 08 May 2019 14:17:25 Z
Horizon Pharma (HZNP) Q1 Earnings and Revenues Top Estimates

Tue, 07 May 2019 23:13:50 Z
What's in the Cards for AcelRx (ACRX) This Earnings Season?

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Drug Manufacturers - Specialty Generic
Shares Out. (M) 184.88
Shares Float (M) 182.30
% Held by Insiders
% Held by Institutions
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS 1.830
EPS Est. Current Year 1.070
EPS Est. Next Year 1.250
EPS Est. Next Quarter 0.230
Forward EPS 1.769
Book Value (p.s.) 4.990
PEG Ratio 0.99
Profit Margin 7.25
Operating Margin 2.19
Return on Assets (ttm) -1.8
Return on Equity (ttm) -7.4
Qtrly Rev. Growth 29.7
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) 194.54
Levered Free Cash Flow (M) 241.67

Stock Valuations

P/E 14.11
P/E Growth Ratio -0.04
P/BV 5.18
P/S 655591680.00
P/CF 24.55

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.